Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer

Abstract Background Liver-type fatty acid-binding protein (L-FABP) is widely expressed in hepatocytes and plays a role in lipid metabolism. It has been demonstrated to be overexpressed in different types of cancer; however, few studies have investigated the association between L-FABP and breast canc...

Full description

Bibliographic Details
Main Authors: Chi-Chang Chang, Chia-Chang Hsu, Teng-Hung Yu, Wei-Chin Hung, Shyh-Ming Kuo, Chia-Chi Chen, Cheng-Ching Wu, Fu-Mei Chung, Yau-Jiunn Lee, Ching-Ting Wei
Format: Article
Language:English
Published: BMC 2023-02-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-023-02944-8
_version_ 1797864505510723584
author Chi-Chang Chang
Chia-Chang Hsu
Teng-Hung Yu
Wei-Chin Hung
Shyh-Ming Kuo
Chia-Chi Chen
Cheng-Ching Wu
Fu-Mei Chung
Yau-Jiunn Lee
Ching-Ting Wei
author_facet Chi-Chang Chang
Chia-Chang Hsu
Teng-Hung Yu
Wei-Chin Hung
Shyh-Ming Kuo
Chia-Chi Chen
Cheng-Ching Wu
Fu-Mei Chung
Yau-Jiunn Lee
Ching-Ting Wei
author_sort Chi-Chang Chang
collection DOAJ
description Abstract Background Liver-type fatty acid-binding protein (L-FABP) is widely expressed in hepatocytes and plays a role in lipid metabolism. It has been demonstrated to be overexpressed in different types of cancer; however, few studies have investigated the association between L-FABP and breast cancer. The aim of this study was to assess the association between plasma concentrations of L-FABP in breast cancer patients and the expression of L-FABP in breast cancer tissue. Method A total of 196 patients with breast cancer and 57 age-matched control subjects were studied. Plasma L-FABP concentrations were measured using ELISA in both groups. The expression of L-FABP in breast cancer tissue was examined using immunohistochemistry. Result The patients had higher plasma L-FABP levels than the controls (7.6 ng/mL (interquartile range 5.2–12.1) vs. 6.3 ng/mL (interquartile range 5.3–8.5), p = 0.008). Multiple logistic regression analysis showed an independent association between L-FABP and breast cancer, even after adjusting for known biomarkers. Moreover, the rates of pathologic stage T2+T3+T4, clinical stage III, positive HER-2 receptor status, and negative estrogen receptor status were significantly higher in the patients with an L-FABP level greater than the median. Furthermore, the L-FABP level gradually increased with the increasing stage. In addition, L-FABP was detected in the cytoplasm, nuclear, or both cytoplasm and nuclear of all breast cancer tissue examined, not in the normal tissue. Conclusions Plasma L-FABP levels were significantly higher in the patients with breast cancer than in the controls. In addition, L-FABP was expressed in breast cancer tissue, which suggests that L-FABP may be involved in the pathogenesis of breast cancer.
first_indexed 2024-04-09T22:54:02Z
format Article
id doaj.art-8f10c690eb014cb8b3bded9fd75a3c72
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-04-09T22:54:02Z
publishDate 2023-02-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-8f10c690eb014cb8b3bded9fd75a3c722023-03-22T11:24:15ZengBMCWorld Journal of Surgical Oncology1477-78192023-02-0121111010.1186/s12957-023-02944-8Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancerChi-Chang Chang0Chia-Chang Hsu1Teng-Hung Yu2Wei-Chin Hung3Shyh-Ming Kuo4Chia-Chi Chen5Cheng-Ching Wu6Fu-Mei Chung7Yau-Jiunn Lee8Ching-Ting Wei9Department of Obstetrics & Gynecology, E-Da Hospital/E-Da Dachang HospitalDivision of Gastroenterology and Hepatology, Department of Internal Medicine, E-Da HospitalDivision of Cardiology, Department of Internal Medicine, E-Da HospitalDivision of Cardiology, Department of Internal Medicine, E-Da HospitalDepartment of Biomedical Engineering, I-Shou UniversityDepartment of Pathology, E-Da HospitalDivision of Cardiology, Department of Internal Medicine, E-Da HospitalDivision of Cardiology, Department of Internal Medicine, E-Da HospitalLee’s Endocrinologic ClinicThe School of Chinese Medicine for Post Baccalaureate, College of Medicine, I-Shou UniversityAbstract Background Liver-type fatty acid-binding protein (L-FABP) is widely expressed in hepatocytes and plays a role in lipid metabolism. It has been demonstrated to be overexpressed in different types of cancer; however, few studies have investigated the association between L-FABP and breast cancer. The aim of this study was to assess the association between plasma concentrations of L-FABP in breast cancer patients and the expression of L-FABP in breast cancer tissue. Method A total of 196 patients with breast cancer and 57 age-matched control subjects were studied. Plasma L-FABP concentrations were measured using ELISA in both groups. The expression of L-FABP in breast cancer tissue was examined using immunohistochemistry. Result The patients had higher plasma L-FABP levels than the controls (7.6 ng/mL (interquartile range 5.2–12.1) vs. 6.3 ng/mL (interquartile range 5.3–8.5), p = 0.008). Multiple logistic regression analysis showed an independent association between L-FABP and breast cancer, even after adjusting for known biomarkers. Moreover, the rates of pathologic stage T2+T3+T4, clinical stage III, positive HER-2 receptor status, and negative estrogen receptor status were significantly higher in the patients with an L-FABP level greater than the median. Furthermore, the L-FABP level gradually increased with the increasing stage. In addition, L-FABP was detected in the cytoplasm, nuclear, or both cytoplasm and nuclear of all breast cancer tissue examined, not in the normal tissue. Conclusions Plasma L-FABP levels were significantly higher in the patients with breast cancer than in the controls. In addition, L-FABP was expressed in breast cancer tissue, which suggests that L-FABP may be involved in the pathogenesis of breast cancer.https://doi.org/10.1186/s12957-023-02944-8Liver-type fatty acid-binding proteinConcentrationsExpressionBreast cancer
spellingShingle Chi-Chang Chang
Chia-Chang Hsu
Teng-Hung Yu
Wei-Chin Hung
Shyh-Ming Kuo
Chia-Chi Chen
Cheng-Ching Wu
Fu-Mei Chung
Yau-Jiunn Lee
Ching-Ting Wei
Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer
World Journal of Surgical Oncology
Liver-type fatty acid-binding protein
Concentrations
Expression
Breast cancer
title Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer
title_full Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer
title_fullStr Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer
title_full_unstemmed Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer
title_short Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer
title_sort plasma levels and tissue expression of liver type fatty acid binding protein in patients with breast cancer
topic Liver-type fatty acid-binding protein
Concentrations
Expression
Breast cancer
url https://doi.org/10.1186/s12957-023-02944-8
work_keys_str_mv AT chichangchang plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT chiachanghsu plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT tenghungyu plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT weichinhung plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT shyhmingkuo plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT chiachichen plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT chengchingwu plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT fumeichung plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT yaujiunnlee plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer
AT chingtingwei plasmalevelsandtissueexpressionoflivertypefattyacidbindingproteininpatientswithbreastcancer